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Background
Seminal Fluid Anaphylaxis (SFA) is a rare condition
caused by IgE mediated sensitization to seminal proteins
during or after coitus. It has been reported about 80 times
in the medical literature ranges in symptomatology from
local pruritus to serious systemic reactions. This is the
first known documented case in Canada.
Methods
One case is presented including clinical course and posi-
tive skin prick testing to husband’s seminal fluid after con-
sultation with an allergist and obtaining written consent.
Results
A 54 year-old woman with no atopic history was referred
for evaluation after four progressive episodes of post-coital
reactions with her husband. The first two episodes con-
sisted of itching of both palms and soles of feet with mini-
mal vaginal pruritus. After abstaining, a third episode a
month later consisted of hives on the patient’sl e g sa n d
back with significant vaginal pruritus. The fourth episode
the patient developed vaginal and generalized pruritus,
urticaria, palpitations and trouble breathing through her
nose, immediately post-coital. All symptoms resolved
spontaneously with no treatment. Skin prick testing was
conducted using the partner’s seminal fluid to confirm the
clinical suspicion of SFA, producing a wheal of 8mm and
flare of 5cm.
Conclusions
The partner’s seminal fluid will be fractionated to deter-
mine the specific amino acid sequence of interest by
serum-specific IgG/IgE by ELISA to the seminal plasma
and plasma proteins. An SDS-PAGE and IgE immunoblot
assay will confirm specific activity to the semen. Of clinical
relevance, mass production of this protein will be used for
local or systemic immunotherapy to prevent future SFA.
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